Toronto, Ontario–(Newsfile Corp. – January 13, 2022) – PharmaDrug Inc. (CSE: PHRX) (OTC: LMLLF) (“ PharmaDrug” or the “Company“), a specialty pharmaceutical company focused on the development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, announces that Mr. Robert Schwartz has resigned from the board of…


Previous articlePT284 – Jonathan Sabbagh – Ketamine-Assisted Psychotherapy and Collaborative Care
Next articlePsychedelic Bulletin: MindMed Co-Founder Resigns from Board; Global Coalition to Reschedule Psilocybin Emerges; We Review Psychedelic Research and Trials from 2021